Teleflex News (NYSE:TFX)

DateTimeSource
Headline
11/16/20175:00PMBWTeleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering
Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its offering of $500.0 million aggregate principal amount of 4.625% senior notes due 2027 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on November 20, 2017, subject to customary closing conditions... More...>>
11/16/20178:00AMBWTeleflex Incorporated Announces Public Offering of $500 Million of Senior Notes
Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the registered public offering, subject to market and other conditions, of $500.0 million aggregate principal amount of senior notes due 2027 (the “Notes”). The interest rate and other terms of the Notes will be determined at pricing. The Notes will... More...>>
11/14/20175:00PMBWTeleflex to Present at the 29th Annual Piper Jaffray Healthcare Conference
Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 29th Annual Piper Jaffray Healthcare Conference at The Lotte New York Palace Hotel, in New York City, on Tuesday, November 28, 2017 at 11:30 a.m. (ET). A live audio webcast of the conference presentation, along with the accompanying... More...>>
11/07/20176:45AMBWTeleflex Receives Innovative Technology Designation from Vizient for LMA® Gastro™ Airway
Designation recognizes products that bring improvements to the health care industry Teleflex Incorporated (NYSE: TFX) announced its LMA® Gastro™ Airway has received a 2017 Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The designation... More...>>
11/02/20176:45AMBWTeleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2017 to shareholders of record at the close of business on November 15, 2017. Additional information about Teleflex... More...>>
11/02/20176:30AMBWTeleflex Reports Third Quarter 2017 Results
Third Quarter Revenues of $534.7 million, up 17.4% Versus Prior Year Period; up 15.4% on Constant Currency Basis Third Quarter GAAP Diluted EPS of $1.70, up 21.4% Over Prior Year Period Third Quarter Adjusted Diluted EPS of $2.12, up 17.8% Versus Prior Year Period Raised 2017 Guidance Range for GAAP Revenue Growth from... More...>>
10/19/20176:45AMBWTeleflex Announces Third Quarter 2017 Earnings Conference Call Information
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, November 2, 2017 Teleflex Incorporated (NYSE: TFX) announced today that financial results for the third quarter 2017 will be released before market open on Thursday, November 2, 2017. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, November... More...>>
10/03/20175:00PMBWTeleflex Introduces CleanSweep™ Technology at AARC Congress 2017
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, will showcase its broad portfolio of products for Respiratory Care at the 70th Anniversary of the American Association for Respiratory Care (AARC) Congress, October 4-7, 2017 in Indianapolis. At the congress... More...>>
10/02/20174:01PMBWTeleflex Incorporated Completes Acquisition of NeoTract
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies designed to improve the health and quality of people’s lives, announced today the completion of its previously announced acquisition of NeoTract, Inc. On September 5, 2017, the two companies announced a definitive agreement for Teleflex... More...>>
09/13/20176:45AMBWTeleflex to Present the Peripheral Intervention Product Portfolio from Its New Subsidiary, Vascular Solutions at the Annual M...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase the product portfolio recently acquired from its new subsidiary, Vascular Solutions, as well as its Arrow® Hemodialysis, Oncology and Peripheral Intervention Solutions at the CIRSE... More...>>
09/11/20176:45AMBWTeleflex to Present at the 47th Annual Meeting of the International Continence Society (“ICS”)
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase its advanced bladder management product lines at the 47th ICS (Annual Meeting of the International Continence Society) in Florence, Italy, on September 12-15, 2017. Teleflex offers one of... More...>>
09/05/20176:45AMBWTeleflex Incorporated to Acquire NeoTract
Significantly advances Teleflex’s offering of urological solutionsProvides differentiated, high-growth and high-margin product offering with demonstrable clinical benefitsCompelling financial profile expected to substantially enhance Teleflex’s revenue growth, margins, earnings and cash flow generation capabilities... More...>>
08/29/20176:45AMBWTeleflex to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 15th Annual Global Healthcare Conference at the Grand Hyatt in New York City, Tuesday, September 12, 2017 at 2:55 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide... More...>>
08/23/20176:45AMBWTeleflex Awarded Group Purchasing Contract with Vizient Inc. for Non-Tunneled Central Venous Catheters
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies for vascular access, has announced a new three year Product Category contract with Vizient Inc. for non-tunneled central venous catheters. Vizient is the largest member-driven health care performance improvement company in the country... More...>>
08/03/20176:45AMBWTeleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2017 to shareholders of record at the close of business on August 15, 2017. Additional information about Teleflex... More...>>
08/03/20176:30AMBWTeleflex Reports Second Quarter 2017 Results
Second Quarter Revenues of $528.6 million, up 11.6% Versus Prior Year Period; up 12.9% on Constant Currency Basis Second Quarter GAAP Diluted EPS of $1.67, up 33.6% Over Prior Year Period Second Quarter Adjusted Diluted EPS of $2.04, up 7.9% Versus Prior Year Period Raised 2017 Guidance Range for GAAP Revenue Growth from... More...>>
07/24/20176:45AMBWArrow® Seldinger Arterial Catheterization Device Receives FDA Market Clearance
Designed for Risk Reduction, Optimal Performance, and Patient Safety Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced today that its Arrow® Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration... More...>>
07/20/20176:45AMBWTeleflex Announces Second Quarter 2017 Earnings Conference Call Information
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, August 3, 2017 Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2017 will be released before market open on Thursday, August 3, 2017. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, August 3... More...>>
06/22/20175:00PMBWTeleflex’s (TFX) Vascular Solutions, Inc. Issues Recall of Venture® Catheters
Vascular Solutions, Inc. voluntarily initiates a worldwide recall of Venture Catheters on April 25, 2017 Teleflex Incorporated (NYSE: TFX), announces a worldwide recall of Venture® Catheters was voluntarily initiated by its Vascular Solutions, Inc. subsidiary on April 25, 2017. Vascular Solutions, Inc. is the manufacturer... More...>>
06/02/20175:00PMBWTeleflex to Showcase Key Anesthesia Products at Euroanaesthesia 2017 (“ESA”) in Geneva
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase the LMA® Protector™ and other key products in its Anesthesia portfolio, together with its innovative Vascular Access platform, at the Euroanesthesia Congress in Geneva, Switzerland on... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V:us D:20171118 02:33:29